NCI Cohort Consortium
The NCI Cohort Consortium is an extramural-intramural partnership formed by the National Cancer Institute (NCI) to address the need for large-scale collaborations to pool the large quantity of data and biospecimens necessary to conduct a wide range of cancer studies. Through its collaborative network of investigators, the Consortium provides a coordinated, interdisciplinary approach to tackling important scientific questions, economies of scale, and opportunities to quicken the pace of research.
Save the Date
Please SAVE THE DATE for the next NCI Cohort Consortium Annual Meeting (Virtual Meeting Format): November 16-17, 2020.
NCI Cohort Consortium Resources for Researchers
NCI Cohort Consortium members have launched more than 40 scientific and technical initiatives.
Propose a New Project
View past and current projects, read the criteria for proposing a new project, and download the project proposal form.
Publications, sorted by Project Name and Publication Date, resulting from the Cohort Consortium's Projects and Working Groups.
A list of funding opportunities from the Division of Cancer Control and Population Sciences (DCCPS) that are currently accepting applications.
Cancer Epidemiology Descriptive Cohort Database (CEDCD)
A searchable database containing descriptive information about cohort studies for cancer incidence, mortality, and other health outcomes.
Cohort Metadata Repository (CMR)
A tool to facilitate data harmonization across participating cohorts and document harmonization decisions in an accessible way.
See how the NCI Cohort Consortium is advancing collaborative cancer epidemiology research.
Figure: 60 Epidemiology Cohorts (36 in North America, 7 in Asia, 16 in Europe, and 1 in Australia; Two cohorts include study participants from both North America and Australia) with > 7 Million Participants (male, female, white, black, asian, hispanic); Biospecimens (inc. plasma/serum, saliva/buccal cells, urine, buffy coat/whole blood, tissues, and nails) have been collected on approx. 2 million individuals; Thousands of biospecimens for major cancer sites (inc. breast, prostate, lung, colon & rectum, melanoma, and bladder); Cohort Consortium members participate in approximately 50 projects which have made scientific discoveries about cancer risk factors and technical advances in cohort methodologies; For membership, Cohorts must have a min. of 10k study participants, cancer endpoints, and commitment to scientific collaborations through participating in pooling studies; To join or collaborate, contact Nonye Harvey, Dr.P.H., M.P.H., at NCICohortConsortium@mail.nih.gov.